Introduction
Activation of a growth factor receptor stimulates a variety of parallel signal transduction cascades. These cascades shuttle the signal into the nucleus, where the expression of genes necessary for cell cycle progression is initiated. One of those genes that become activated early after growth factor stimulation of arrested cells is the c-myc gene (MuÈ ller et al., 1984) . The c-myc gene encodes a sequence speci®c DNAbinding protein which is involved in control of gene transcription (Amati and Land, 1994) . The expression of the c-Myc protein correlates with the proliferative status of cells and its function has been shown to be necessary for cell proliferation (Waters et al., 1991; Heikkila et al., 1987) . The overexpression of the cMyc protein can contribute to the oncogenic transformation of cells (Cooper, 1995) . The Ras GTPase plays a central role in growth factor induced signal transduction events. Mutations generating a constitutively active form of the Ras protein are highly oncogenic and are frequently found in human cancer. Inhibition of Ras function blocks cell proliferation (Dobrowolski et al., 1994) . Oncogenic Ras and Myc cooperate in the transformation of primary rat embryo ®broblasts (Land et al., 1983) , leading to the opinion that c-Myc and Ras are on separate pathways. Recently the regulation of c-myc expression has been discussed controversially. Data showing that a block in S phase induction by dominant negative Src or Ras mutants can be overcome by Myc overexpression only in the case of the dominant negative Src argues that a Src and not Ras mediated signaltransduction pathway is responsible for the c-myc induction (Barone and Courtneidge, 1995) . However there is also evidence that the c-myc gene is regulated by Ras mediated signalling. De®ciencies in the Ras pathway caused by overexpression of the carboxy-terminal catalytic domain of the GTPase-activating protein (GAP) has been shown to be rescued by c-myc overexpression (Bortner et al., 1992) . Furthermore the human and mouse c-myc promoters contain binding sites for the Ets transcription factors (Roussel et al., 1994) . Ets-1 can transactivate reporter genes driven by the human and mouse c-myc promoters (Roussel et al., 1994) . The Ets-1 and Ets-2 transcription factors can be activated by Ras/Raf/Mek/Erk signalling (McCharty et al., 1997; Wasylyk et al., 1997; Yang et al., 1996) , indicating a role for Ras/Raf signalling in the regulation of the c-myc gene. By employing conditional cell lines harboring an inducible Ras inhibitory protein and an inducible constitutive active form of the c-Raf-1 protein we have addressed the question if the Ras/Raf signal transduction pathway is involved in the regulation of the c-myc gene expression.
Results
The c-Raf-1 protein has a N-terminal regulatory domain and a C-terminal kinase domain (Figure 1 ). The regulatory domain interacts directly with the Ras eector domain (Daum et al., 1994) . By this interaction the c-Raf-1 protein becomes translocated to the cellular membrane (Leevers et al., 1994 ). This step has been shown to be essential in the activation of the c-Raf-1 kinase by growth factors. Deletion of the regulatory domain generates a constitutive active kinase (Stanton et al., 1989; Heidecker et al., 1990) . Fusion of the cRaf-1 kinase domain to the hormone binding domain of the estrogen receptor provides a hormone regulated form of the c-Raf-1 kinase (Figure 1 ) (Samuels et al., 1993; Kerkho and Rapp, 1997) . We have established a NIH3T3 based cell line stably expressing a chimeric c-Raf-1-estrogen receptor protein (c-Raf-1-BxB-ER TM , N-BxB-ER TM ) (Figure 2a ) (Kerkho and Rapp, 1997) . Addition of the estrogen antagonist 4-hydroxytamoxifen (OHT) to proliferating or arrested con¯uent NBxB-ER TM cells induces a strong and sustained activation of the Erk kinases within 1 h (Kerkho and Rapp, 1997) . Under low serum conditions the activation of the Erk kinases is less pronounced (Samuels and McMahon, 1994; Kerkho and Rapp, 1997) . In addition to the early activation of the c-Raf-1-BxB-ER TM kinase activity, the presence of OHT leads also to an increase in the protein concentration of the fusion protein within 12 ± 24 h (Figure 2a ). Constitutive activation of the oncogenic c-Raf-1 protein in N-BxB-ER TM cells has been shown to be sucient to drive cells arrested by con¯uency or serum starvation back into the cell cycle (Kerkho and Rapp, 1997) . In agreement with the dierences in Erk activation, the kinetics of the cell cycle re-entry are delayed in the case of the serum starved cells.
In Although the c-fos promoter has been shown to be induced by Ras/Raf signalling in transient promoter assays (Jamal and Zi, 1990) , cells transformed by oncogenic Raf do not express steady state levels of cfos (Siegfried and Rapp et al., 1994) . Consistent with the observation that the expression of c-fos is transient in Raf transformed cells we do not see a signi®cant increase of c-fos mRNA between 2 and 12 h of OHT induction in arrested N-BxB-ER TM cells (Figure 3) .
The isolated regulatory domain of the c-Raf-1 protein (c-Raf-1-C4) (Figure 1 ) has been shown to inhibit Ras function by interacting with the Ras eector domain (Bruder et al., 1992; Daum et al., 1994) . We have generated NIH3T3 cells expressing a tagged version of the c-Raf-1-C4 protein (c-Raf-1-C4B) under the control of a tetracycline responsive promoter (N-C4B-tet). In the presence of tetracycline the expression is repressed (Figure 2b) . Removal of the tetracycline leads to an accumulation of the c-Raf-1-C4B protein and inhibits serum mediated proliferation of these cells (Figure 2b,c) . N-C4B-tet cells were cultured in the presence and absence of tetracycline and subsequently serum starved for a period of 6 h. During this period the levels of c-myc mRNA declined to nearly undetectable levels (data not shown). Northern hybridisation of RNA samples isolated 1 h following serum stimulation revealed, that in cells expressing the c-Raf-1-C4B protein the induction of the c-myc gene is markedly reduced compared to cells where the expression of the Ras inhibitor is suppressed by tetracycline (Figure 4) . These results strongly indicate that Ras function is essential for serum mediated c-myc expression in NIH3T3 cells. Serum induced expression of the c-fos gene is also signi®cantly reduced in the presence of the Ras inhibitor, underlining the role of the Ras signal in the regulation of this immediate early gene.
A number of groups have reported a cooperation of the oncogenic Ras or Raf proteins with the c-Myc protein in cell transformation (Cooper, 1995; Morse III and Rapp, 1988) 
Discussion
The regulation of the c-myc gene has been discussed controversely in the past. Data supporting a role of the Ras/Raf signaltransduction cascade in this process have been published (Bortner et al., 1992; Roussel et al., 1994; McCharty et al., 1997; Wasylyk et al., 1997) as well as data showing that a Src and not a Ras dependent pathway is essential for growth factor mediated c-myc induction (Barone and Courtneidge, 1995) . In order to analyse the role of the Ras/Raf signaltransduction cascade in the regulation of the cmyc gene we have established stable conditional cell lines where we can speci®cally activate the Raf pathway or inhibit Ras function by external stimuli. The Raf/Mek/Erk signaltransduction cascade is one of several parallel cascades activated by Ras signalling (Daum et al., 1994; Avruch et al., 1994; Rodriguez Viciana et al., 1996; Symons 1996) . Induction of the cRaf-BxB-ER TM protein in N-BxB-ER TM cells by OHT leads to a rapid and sustained induction of the Erk kinases. With a delay of 2 ± 6 h this signal leads to an induction of c-myc expression. The oncogenic c-Raf-1 kinase is not able to directly activate other parallel signaltransduction cascades like the Mekk/Sek/Jnk cascade during this time period (Minden et al., 1994) . Our results therefore show that the isolated Raf/Mek/ Erk signaltransduction cascade is sucient to induce the expression of the c-myc gene. These results strongly support a role of Raf in the induction of c-myc expression. The mechanism how Raf signalling activates c-myc expression remains to be established. The induction kinetics of 2 ± 6 h do not exclude a direct activation of the c-myc promoter by Erk mediated activation of the Ets transcription factors. However a more indirect multistep process could also be possible The downstream regulatory elements however remain to be analysed in order to get a more complete understanding of the regulation of the c-myc gene.
Materials and methods

Cell lines
N-BxB-ER TM cells were obtained by liposome mediated transfection (Lipofectamine, Gibco) of NIH3T3 cells with the BJ4-BxB-ER TM plasmid (Kerkho and Rapp, 1997) . After transfection the cells were cultured in the presence of 4-hydroxytamoxifen (OHT). N-BxB-ER TM cells were then isolated from a focus of transformed cells. N-BxB-ER TMMyc cells were obtained by infection of N-BxB-ER TM cells with replication incompetent retroviruses expressing the cmyc gene and the neomycin resistance gene as a selection marker. Infected cells were selected in the presence of 500 mg/ml G418. Retroviruses were obtained from the supernatant of GP+E packaging cells (Markowitz et al., 1988) transfected by lipofection (Lipofectamine, Gibco) with the pSRMSVTKneo-c-myc vector (Sawyers et al., 1992) . For enrichment of transfected virus producing cells, the cells were cultured for two weeks in the presence of 500 mg/ml G418. For the generation of N-C4B-tet cells, NIH3T3 cells were ®rst transfected by a standard calcium phosphate precipitation method with the pUHD-15-1 plasmid (Gossen and Bujard, 1992 ) expressing a tet repressor-VP16 fusion protein and the pSV-neo plasmid mediating G418 resistance. For the selection the cells were cultured for two weeks in the presence of 500 mg/ml G418. Selected clones were further transfected by lipofection (Lipofectamine, Gibco) with the pUHG-10-3-C4B vector and the pBabe-puro vector (Morgenstern and Land, 1990) . The pUHG-10-3-C4B vector was constructed by inserting a XhoI ± XbaI fragment from the RSV-C4B vector (Bruder et al., 1992) into the SacII ± XbaI sites of the pUHG-10-3 vector (Gossen and Bujard, 1992) . Following puromycin selection (6 mg/ml) in the presence of tetracycline (1 mg/ml), clones were tested for tetracycline regulated expression of the c-Raf-1-C4B protein by Western hybridization. N-BxB-ER TM based cells were routinely cultured in DMEM medium (Gibco) supplemented with 10% fetalcalf serum (PAA), 100 units/ml penicillin (Gibco), 100 mg/ml streptomycin (Gibco) and 200 nM OHT. N-C4B-tet cells cultured in DMEM supplemented with 10% fetal calf serum (PAA), 100 units/ml penicillin (Gibco), 100 mg/ml streptomycin (Gibco) and 1 mg/ml tetracycline.
Northern blotting
RNA analyses were performed as described earlier (Kerkho and Rapp, 1997) . The following cDNA probes have been used: c-myc, 1.0 kb XbaI ± SacI fragment of pSV2-myc (Kelekar and Cole, 1986) ; c-fos, 1.4 kb EcoRI fragment of c-fos-Deg-14 (a kind gift from Rodrigo Bravo), c-Raf-1-C4B, 1 kb XhoI ± XbaI fragment of RSV-C4B (Rapp lab) . For reuse of the membrane the hybridized labelled DNA probes were stripped o by pouring a boiling solution containing 15 mM sodium chloride, 1.5 mM sodium citrate and 0.1% SDS over the membrane. The membrane was incubated in the solution for 15 min on a shaker. The procedure was repeated twice.
Immunoblotting
Total cellular protein extracts have been obtained by lysing the cells in protein sample buer (60 mM Tris-HCl pH 6.8, 10% (w/v) Glycerin, 3% (w/v) SDS, 5% (w/v) 2-mercaptoethanol, 0.005% (w/v) bromphenolblue). Western blot experiments were performed as described earlier (Kerkho and Rapp, 1997) . For immunodetection the following antibodies were used: c-Raf-1, 30K, rabbit polyclonal, 1 : 750 dilution, Rapp lab; B-Raf, rabbit polyclonal, 1 : 1000, Rapp lab.
